[Comparison of the effects of intensified lifestyle and glucagon-like peptide-1 receptor agonist combined with lifestyle intervention on body composition in adult patients with overweight or obesity]
- PMID: 41083404
- DOI: 10.3760/cma.j.cn112137-20250305-00530
[Comparison of the effects of intensified lifestyle and glucagon-like peptide-1 receptor agonist combined with lifestyle intervention on body composition in adult patients with overweight or obesity]
Abstract
Objective: Comparison of the impact of intensified lifestyle and glucagon-like peptide-1 receptor agonist (GLP-1RA) combined with lifestyle intervention on body composition in adult patients with overweight or obesity. Methods: The clinical data of 197 overweight or obese patients who were treated at the Zhongshan Hospital, Fudan University from February 2022 to June 2024 were retrospectively analyzed, including 75 males and 122 females, aged (36.7±10.9) years. Patients were divided into an intensified lifestyle intervention group (n=84) and a GLP-1RA combined with lifestyle therapy group (n=113) based on the intervention approach. Collected clinical data of patients. After adjusting for gender, age, and baseline BMI using generalized linear models, analyze the association between the changes in various indicators [including body weight, body mass index (BMI), body fat percentage, fat mass (FM), fat mass index (FMI), fat-free mass (FFM), and fat-free mass index (FFMI)] and the intervention methods. Results: Body weight, BMI, waist circumference, diastolic blood pressure, FM, FFM, FMI, FFMI, fasting blood glucose, insulin resistance index, alanine aminotransferase, and controlled attenuation parameter were lower in the intensive lifestyle intervention group compared to the GLP-1RA combined with lifestyle intervention group (all P0.05). There was no statistically significant difference between the two groups in terms of age, gender, systolic blood pressure, body fat percentage, total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, aspartate aminotransferase, and elasticity values (all P0.05). After 12 weeks of intervention, the results of the generalized linear model showed that the reduction magnitudes of body weight, FFM, and FFMI were associated with the intervention methods (all P0.05). The GLP-1RA combined with lifestyle intervention group showed greater reductions in body weight [(7.8±4.3) vs (5.1±4.5) kg], FFM [(2.2±2.1) vs (1.0±1.9) kg], and FFMI [(0.7±0.5) vs (0.3±0.5) kg/m2] compared to the intensive lifestyle intervention group (all P0.05). After 24 weeks of intervention, both groups exhibited decreases in post-weight-loss body weight, BMI, body fat percentage, FM, FFM, FMI, and FFMI compared to pre-weight-loss values (all P0.001). The results of the generalized linear model indicated that the reduction magnitudes of body fat percentage, FM, FFM, FMI, and FFMI were associated with the intervention methods (all P0.05). The intensive lifestyle intervention group showed greater reductions in body fat percentage (5.8%±3.0% vs 3.9%±4.2%), FM[(8.9±4.1) vs (7.0±5.7) kg], and FMI [(3.1±1.4) vs (2.4±1.9) kg/m2] compared to the GLP-1RA combined with lifestyle intervention group, while the reductions in FFM [(1.5±2.5) vs (2.8±3.4) kg] and FFMI [(0.5±0.9) vs (0.9±1.2) kg/m2] were smaller (all P0.05). Conclusion: In weight loss treatment, the intensive lifestyle retains more lean body mass than the GLP-1RA combined lifestyle.
目的: 比较强化生活方式和胰高血糖素样肽-1受体激动剂(GLP-1RA)联合生活方式干预对超重或肥胖成人患者人体成分的影响。 方法: 回顾性分析2022年2月至2024年6月于复旦大学附属中山医院就诊治疗的197例超重或肥胖成人患者的临床资料,男75例,女122例,年龄(36.7±10.9)岁。根据干预方式分为强化生活方式干预组(n=84)和GLP-1RA联合生活方式干预组(n=113)。收集患者临床资料。采用广义线性模型校正性别、年龄和基线BMI后分析患者体重、体质指数(BMI)、体脂率、体脂质量(FM)、体脂质量指数(FMI)、去脂体质量(FFM)和去脂体质量指数(FFMI)等指标的变化幅度与干预方式的关联。 结果: 强化生活方式干预组患者的体重、BMI、腰围、舒张压、FM、FFM、FMI、FFMI、空腹血糖、胰岛素抵抗指数、丙氨酸转氨酶和受控衰减参数均低于GLP-1RA联合生活方式干预组(均P0.05)。两组患者年龄、性别、收缩压、体脂率、总胆固醇、甘油三酯、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、天冬氨酸转氨酶和弹性值差异均无统计学意义(均P0.05)。干预12周后,广义线性模型结果显示,体重、FFM和FFMI下降幅度与干预方式均有关联(均P0.05)。GLP-1RA联合生活方式干预组下降的体重[(7.8±4.3)比(5.1±4.5)kg]、FFM[(2.2±2.1)比(1.0±1.9)kg]和FFMI[(0.7±0.5)比(0.3±0.5)kg/m2]大于强化生活方式干预组(均P0.05)。干预24周后,两组患者减重后体重、BMI、体脂率、FM、FFM、FMI、FFMI较减重前均下降(均P0.001)。广义线性模型结果显示,体脂率、FM、FFM、FMI、FFMI下降幅度与干预方式均有关联(均P0.05)。强化生活方式干预组体脂率(5.8%±3.0%比3.9%±4.2%)、FM[(8.9±4.1)比(7.0±5.7)kg]和FMI[(3.1±1.4)比(2.4±1.9)kg/m2]下降幅度均大于GLP-1RA联合生活方式干预组,FFM[(1.5±2.5)比(2.8±3.4)kg]和FFMI[(0.5±0.9)比(0.9±1.2)kg/m2]下降幅度均小于GLP-1RA联合生活方式组(均P0.05)。 结论: 强化生活方式较GLP-1RA联合生活方式干预在减重中保留更多的瘦体重。.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
